Literature DB >> 16723597

In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.

Manuel Cuenca-Estrella1, Alicia Gomez-Lopez, Maria J Buitrago, Emilia Mellado, Guillermo Garcia-Effron, Juan L Rodriguez-Tudela.   

Abstract

The activities of 10 combinations of antifungal agents against 25 clinical isolates of Scopulariopsis brevicaulis were tested by the checkerboard technique. An average indifferent effect was detected for all combinations. Synergy was observed for some isolates and combinations, particularly with posaconazole-terbinafine (68% of strains), amphotericin B-caspofungin (60%), and posaconazole-caspofungin (48%).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16723597      PMCID: PMC1479145          DOI: 10.1128/AAC.00162-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi.

Authors:  J L Rodriguez-Tudela; Erja Chryssanthou; Evangelia Petrikkou; Juan Mosquera; David W Denning; Manuel Cuenca-Estrella
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Emilia Mellado; Maria J Buitrago; Araceli Monzón; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

3.  In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

Authors:  Sevtap Arikan; Mario Lozano-Chiu; Victor Paetznick; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Emilia Mellado; Guillermo Garcia-Effron; Araceli Monzon; Juan Luis Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

5.  Microascus cinereus (Anamorph scopulariopsis) brain abscess in a bone marrow transplant recipient.

Authors:  J W Baddley; S A Moser; D A Sutton; P G Pappas
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Scopulariopsis fungus ball.

Authors:  Shunsuke Endo; Mitsugu Hironaka; Fumio Murayama; Tsutomu Yamaguchi; Yasunori Sohara; Ken Saito
Journal:  Ann Thorac Surg       Date:  2002-09       Impact factor: 4.330

Review 7.  Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.

Authors:  W J Steinbach; W A Schell; J L Miller; J R Perfect; P L Martin
Journal:  J Infect       Date:  2004-01       Impact factor: 6.072

8.  Scopulariopsis associated meningitis in adult Nigerian AIDS patient--a case report.

Authors:  C Nwabuisi; A K Salami; N A Abdullahi; O O Agbede
Journal:  West Afr J Med       Date:  2003-12

Review 9.  Human hyalohyphomycoses: a review of human infections due to Acremonium spp., Paecilomyces spp., Penicillium spp., and Scopulariopsis spp.

Authors:  M K Schinabeck; M A Ghannoum
Journal:  J Chemother       Date:  2003-11       Impact factor: 1.714

10.  In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.

Authors:  Itamar Shalit; Yona Shadkchan; Zmira Samra; Nir Osherov
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

View more
  12 in total

1.  In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.

Authors:  Magdalena Skóra; Małgorzata Bulanda; Tomasz Jagielski
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

2.  Drug combinations against Mucor irregularis in vitro.

Authors:  Shuzhen Zhang; Ruoyu Li; Jin Yu
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

3.  Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species.

Authors:  Katihuska Paredes; Javier Capilla; Emilio Mayayo; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

4.  Invasive Scopulariopsis alboflavescens infection in patient with acute myeloid leukemia.

Authors:  Keiji Kurata; Sho Nishimura; Hiroya Ichikawa; Rina Sakai; Yu Mizutani; Kei Takenaka; Seiji Kakiuchi; Yoshiharu Miyata; Akihito Kitao; Kimikazu Yakushijin; Shinichiro Kawamoto; Katsuya Yamamoto; Mitsuhiro Ito; Hiroshi Matsuoka; Issei Tokimatsu; Katsuhiko Kamei; Hironobu Minami
Journal:  Int J Hematol       Date:  2018-07-09       Impact factor: 2.490

5.  Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patient.

Authors:  Daniela Gavril; Paul-Louis Woerther; Aicha Ben Lakhdar; Linda Mahjoubi; Emilie Routier; Elisabeth Chachaty; Bertrand Gachot; Stephane De Botton; Jean-Baptiste Micol; Christophe Willekens
Journal:  Infection       Date:  2016-12-01       Impact factor: 3.553

6.  Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.

Authors:  Charline Miossec; Florent Morio; Thierry Lepoivre; Patrice Le Pape; Dea Garcia-Hermoso; Françoise Gay-Andrieu; Alain Haloun; Michele Treilhaud; François Leclair; Michel Miegeville
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

7.  In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.

Authors:  Limin Yao; Zhe Wan; Ruoyu Li; Jin Yu
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

8.  21-year retrospective study of the prevalence of Scopulariopsis brevicaulis in patients suspected of superficial mycoses.

Authors:  Anna B Macura; Magdalena Skóra
Journal:  Postepy Dermatol Alergol       Date:  2015-06-15       Impact factor: 1.837

9.  Sinusitis caused by Scopulariopsis brevicaulis: Case report and review of the literature.

Authors:  Laurent Sattler; Marcela Sabou; Amina Ganeval-Stoll; Caroline Dissaux; Ermanno Candolfi; Valérie Letscher-Bru
Journal:  Med Mycol Case Rep       Date:  2014-06-04

10.  First reported case of disseminated Microascus gracilis infection in a lung transplant patient.

Authors:  Yanna Ding; Lisa L Steed; Nicholas Batalis
Journal:  IDCases       Date:  2020-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.